Semaglutide is a medication called a “GLP-1 receptor agonist.” Semaglutes were originally used to help people with type 2 diabetes. As the course of this FDA-approved treatment continued, researchers realized their patients were achieving improvements in their type 2 diabetes, and they were also experiencing significant weight loss. In 2022, the FDA approved semaglutide as a weight loss treatment.